Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

A patient with steroid sulfatase deficiency had a unique hair pattern and a brain malformation not previously linked to the condition.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Lower irisin levels in the blood may indicate more severe acne.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Using rodents for research shows that health problems in the womb can cause diseases later in life.